About PredOmix
PredOmix is a company based in Gurugram (India) founded in 2018 by Kanury Venkata Subba Rao. PredOmix has raised $661.7 thousand across 1 funding round from investors including Manish Shashikant Anadkat and Indu Rao. PredOmix offers products and services including OncoVeryx Test. PredOmix operates in a competitive market with competitors including Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others.
- Headquarter Gurugram, India
- Founders Kanury Venkata Subba Rao
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Predomix Technologies Pvt. Ltd.
- Jurisdiction Sadar Bazar, Haryana, India
-
Annual Revenue
Not available
-
Net Profit
-$207.13 K (USD)0as on Mar 31, 2020
-
EBITDA
-$144.68 K (USD)0as on Mar 31, 2020
-
Total Equity Funding
$661.7 K (USD)
in 1 rounds
-
Latest Funding Round
$661.7 K (USD), Seed
Jun 25, 2019
-
Investors
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PredOmix
PredOmix offers a comprehensive portfolio of products and services, including OncoVeryx Test.
Blood test for early detection of multiple cancers using metabolomics.
Funding Insights of PredOmix
PredOmix has successfully raised a total of $661.7K through 1 strategic funding round. The most recent funding activity was a Seed round of $661.7 thousand completed in June 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in PredOmix
PredOmix has secured backing from 2 investors, including angel investors. Prominent investors backing the company include Manish Shashikant Anadkat and Indu Rao.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
MS
Manish Shashikant Anadkat |
-
|
Locked | Locked | Locked |
|
IR
Indu Rao |
-
|
Locked | Locked | Locked |
Investor details for PredOmix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PredOmix
Investment portfolio details for PredOmix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PredOmix
Detailed financials for PredOmix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Predomix Comparisons
Peer comparison for PredOmix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PredOmix
PredOmix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
|
| Locked | Locked | Locked |
Blood-based liquid biopsy tests for multiple cancer detection are provided.
|
Detailed competitors of PredOmix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Predomix
Complete news archive for PredOmix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PredOmix
PredOmix was founded in 2018 and raised its 1st funding round 1 year after it was founded.
PredOmix is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.
PredOmix is a funded company, having raised a total of $661.7K across 1 funding round to date.
PredOmix was founded in 2018 and is headquartered in Gurugram, India. The company operates in the health technology sector, focusing on oncology diagnostics. A proprietary technology called OncoVeryx-F is utilized, which combines metabolomics analysis with deep learning algorithms. This approach enables early cancer detection through a single, non-invasive blood test. Operations emphasize research and development for accessible diagnostic solutions in the Indian market and beyond.
PredOmix's top competitors include Guardant Health, Exact Sciences and Foundation Medicine.
PredOmix offers OncoVeryx Test.
PredOmix has 2 investors. Key investors include Manish Shashikant Anadkat, and Indu Rao.
The valuation of PredOmix is $3.31M as of Jun 2019.